维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Mano MS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	The17q12-q21amplicon:Her2 and topoisomerase-IIalpha and their importance to the biology of solid tumours显示文摘	Mano MS Rosa DD De Azambuja E	2007	Cancer Treat Rev2007，33，：	1
2	Rates of TOPOⅡ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A DiLeo A	2004	Gynecologic Oncology2004，92，6：	1
3	The 17q12 - q21 amplicon: Her2 and topoisomerase-Ⅱalpha and their importance to the biology of solid tttmours 显示文摘	Mano MS Rosa DD De Azambuja E	2007	Cancer Treat Rev2007，33，1：	1
4	Rates of II-alpha and H ER2 gene amplification and epithelial ovarian carcinoma 显示文摘	Mano MS topoisomerase expression in Oncol 2004 Awada A Di Leo A	2004	Gynecol2004，92，3：	1
5	Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy显示文摘	Mano MS Fraser G Kerr J	2006	Breast2006，15，1：	1
6	Adjuvant anthracycline-based chemotherapy for early breast cancer: do the dose and schedule matter? 显示文摘	Mano MS Awada A Kerr J	2005	Cancer Treat Rev2005，31，：	1
7	Current management of ovarian carcimosarcoma 显示文摘	Mano MS Rosa DD Azambuja E	2007	Int Gynecol Cancer2007，17，2：	1
8	Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy 显示文摘	Mano MS Fraser G Kerr J	2006	Breast2006，，：	1
9	Rates of topoisomcrase Ⅱ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma 显示文摘	Mano MS Awada A Di Leo A	2004	Gynecol Oncol2004，92，3：	1
10	Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy 显示文摘	Mano MS Fraser G Kerr J	2006	Breast2006，15，：	1
11	Rates of topoisomerase II-al- pha and HER-2 gene amplification and expression in epithelial ovari- an carcinoma显示文摘	Mano MS Awada A Di Leo A	2004	Gynecol Oneol2004，92，3：	1
12	Rates of topoisomerase Ⅱ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A Di Leo A	2004	Gynecol Oncol2004，92，：	1
13	Current management of o- varian carcinosarcoma 显示文摘	Mano MS Rosa DD Azambuja E	2007	Int J Gynecol Cancer2007，17，2：	1
14	Rates of TOPO ]I -alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A DiLeo A	2004	Gynecologic Oncology2004，92，6：	1
15	Rtes of topomerase Topo Ⅱ -alpha and HER2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A DiLeo A	2004	Gynecologic Oncology2004，92，6：	1
16	Rates of TOPOc-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A DiLeo A	2004	Gynecologic Oncology2004，92，6：	1
17	Ki-67 as prognostic marker in early breast cancer:a meta-analysis of published studies involving 12,155 patients显示文摘	de Azambuja E Cardoso F de Castro G Jr Colozza M Mano MS Durbecq V	2007	Br J Cancer2007，96，10：	1
18	Rates of topoisomerase Ⅱ-alpha and HER-2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A Di Leo A	2004	Gynecol Oncol2004，92，3：	1
19	Rates of topoisomerase Ⅱ - alpha and HER - 2 gene amplification and expression in epithelial ovarian carcinoma显示文摘	Mano MS Awada A Di Leo A	2004	Gynecol Oncol2004，92，3：	1
20	Novel cytotoxic drugs: old challenges, new solutions 显示文摘	Ismael GF Rosa DD Mano MS	2008	Cancer Treat Rev2008，34，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示